Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817160-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
62,666
Total Value
$26,319.72
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Feb 3, 2026 | Exercise/Conversion | 31,333 | $0.84 | $26,319.72 | 115,005 | Direct | โ | View Details | |
Chief Scientific Officer | Employee Stock Option (right to buy) | Derivative | Feb 3, 2026 | Exercise/Conversion | 31,333 | $0.00 | $0.00 | 0 | Direct | โ | View Details |